TARK has successfully advised Swiss drug manufacturer Acino on acquisition of medication packing plant from drug manufacturer Takeda. TARK transaction team has provided full legal support to Acino during the extensive acquisition process. TARK´s partners Lada Riisna, Hannes Küün, Tanel Tark, Marit Savi and senior associate Tanel Küün were involved in this project.
Acino International AG develops, manufactures, and markets pharmaceuticals in novel drug delivery forms worldwide. The company hires more than 1,300 employees.
The packaging site located in Põlva, in Estonia, is an excellent opportunity for Acino to support its emerging markets and out-licensing activities, and to grow its contract manufacturing business. The purchased medication packaging plant`s target markets include the Baltic States, Europe and Russia, while the drugs packaged at the plant are brought in from manufacturing plants in Germany, Denmark and Poland. Sales revenue and net profit of the Põlva factory in 2014 and 2015 were at 25,743,000 euros and 929,000 euros, respectively, in both years.